Condition
Serous Cystadenoma
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Terminated1
Completed1
Active Not Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07657884Not ApplicableRecruitingPrimary
Assessment of the Usefulness of SMI (Superb Vascular Imaging) for the Characterisation of Pancreatic Cystic Tumours (IMAKYST)
NCT07463872Recruiting
Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data
NCT03305146Not ApplicableActive Not Recruiting
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT02523170Not ApplicableCompleted
A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas
NCT02494388Terminated
Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Showing all 5 trials